BioMarin Announces Third Quarter 2020 Total Revenues of $477 Million

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. ORCL

Go back to BioMarin Announces Third Quarter 2020 Total Revenues of $477 Million

BioMarin Pharma (BMRN) Tops Q3 EPS, Lowers FY Revenue Guidance

November 5, 2020 4:21 PM EST

BioMarin Pharma (NASDAQ: BMRN) reported Q3 GAAP EPS of $4.01, which may not compare to the analyst estimate of $1.29. Revenue for the quarter came in at $476.8 million versus the consensus estimate of $454.64 million.

GUIDANCE:

BioMarin Pharma sees FY2020 revenue of $1.81-1.87... More